| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/09/2012 | US20120035158 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions |
| 02/09/2012 | US20120035155 Indole-2-carboxamide deivative |
| 02/09/2012 | US20120035154 Modulators of Cellular Adhesion |
| 02/09/2012 | US20120035150 Mif inhibitors and their uses |
| 02/09/2012 | US20120035149 Prokineticin Receptor Antagonists And Uses Thereof |
| 02/09/2012 | US20120035141 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management |
| 02/09/2012 | US20120035140 Carbamoylphosphonates as inhibitors and uses thereof |
| 02/09/2012 | US20120035127 Process for the production of a composition, the composition and the use thereof as food additive |
| 02/09/2012 | US20120035120 Glycolipids as treatment for disease |
| 02/09/2012 | US20120035106 Use of apl-type peptide for treating intestinal inflammatory diseases and type 1 diabetes |
| 02/09/2012 | US20120035105 Insulin Therapies for the Treatment of Diabetes, Diabetes Related Ailments, and/or Diseases or Conditions Other Than Diabetes or Diabetes Related Ailments |
| 02/09/2012 | US20120035104 Insulin derivatives |
| 02/09/2012 | US20120035103 Method for administration of insulin and pharmaceutical composition thereof |
| 02/09/2012 | US20120035102 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| 02/09/2012 | US20120035101 Long-acting growth hormone and methods of producing same |
| 02/09/2012 | US20120035100 Satiation peptide administration |
| 02/09/2012 | US20120035099 Fgf21 analogues and derivatives |
| 02/09/2012 | US20120034326 Novel herbal formulation advocated for the prevention and management of coronary heart disease |
| 02/09/2012 | US20120034323 Compositions and methods for promoting weight loss and increasing energy |
| 02/09/2012 | US20120034321 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
| 02/09/2012 | US20120034308 Reduced-cholesterol dairy product for use as a medicament |
| 02/09/2012 | US20120034303 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
| 02/09/2012 | US20120034302 Particulate composition and the method of making the same |
| 02/09/2012 | US20120034299 Compositions for the treatment of gluten intolerance and uses thereof |
| 02/09/2012 | US20120034298 Chewable Soft Capsule |
| 02/09/2012 | US20120034274 Pharmaceutical composition comprising one or more fumaric acid esters |
| 02/09/2012 | US20120034245 Single-chain multivalent binding proteins with effector function |
| 02/09/2012 | US20120034243 Method of Administering an Antibody |
| 02/09/2012 | US20120034233 Methods of Treating an Overweight or Obese Subject |
| 02/09/2012 | US20120034232 Tlr3 binding agents |
| 02/09/2012 | US20120034221 T-Cell Receptor Antibodies And Methods of Use Thereof |
| 02/09/2012 | US20120034212 Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases |
| 02/09/2012 | US20120034209 Treatment |
| 02/09/2012 | US20120034201 Composition for regulating lipid metabolism |
| 02/09/2012 | US20120034199 Monogastric animal feed |
| 02/09/2012 | US20120034198 Carriers for storage and delivery of biologics |
| 02/09/2012 | US20120034195 Placental stem cells derive from post-partum manmalian placenta, and uses and methods of treatment using said cells |
| 02/09/2012 | US20120034160 Dual variable domain immunoglobulins and uses thereof |
| 02/09/2012 | US20120034159 Antibodies that bind both bcma and taci |
| 02/09/2012 | CA2807552A1 Engineered nucleic acids and methods of use thereof |
| 02/09/2012 | CA2807520A1 Soybean extracts for the treatment of hepatic disorders |
| 02/09/2012 | CA2807174A1 Use of inhibitors of porphobilinogen deaminase in the treatment of congenital erythropoietic porphyria |
| 02/09/2012 | CA2805206A1 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf |
| 02/08/2012 | EP2415868A1 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody |
| 02/08/2012 | EP2415767A1 Poly (ADP-ribose) Polymerase (PARP) Inhibitors |
| 02/08/2012 | EP2415473A1 Oral Care Compositions Containing Combinations of Anti-Bacterial and Host-Response Modulating Agents |
| 02/08/2012 | EP2415466A1 Orally disintegrating coated tablet |
| 02/08/2012 | EP2415465A1 Stabiliser-free pharmaceutical compositions of tetrahydrolipstatin |
| 02/08/2012 | EP2414521A2 Regulation of mir-33 micrornas in the treatment of cholesterol-related disorders |
| 02/08/2012 | EP2414366A1 Spiro derivatives for the modulation of stearoyl-coa desaturase |
| 02/08/2012 | EP2414348A1 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders |
| 02/08/2012 | EP2414334A1 Bridged bicyclic heterocycle derivatives and methods of use thereof |
| 02/08/2012 | EP2413925A1 Satiety-inducing composition |
| 02/08/2012 | EP2413718A1 Reduction of risk of obesity |
| 02/08/2012 | EP2413693A1 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof |
| 02/08/2012 | EP2176251B1 5-pyridinone substituted indazoles and pharmaceutical compositions thereof |
| 02/08/2012 | EP2098515B1 Substituted carbinol compound |
| 02/08/2012 | CN1695713B 一种治疗糖尿病的药物及其制备和质量控制方法 Drugs for treating diabetes and its preparation and quality control methods |
| 02/08/2012 | CN1671836B 用于基因治疗的原代培养脂肪细胞 For gene therapy of primary cultured adipocytes |
| 02/08/2012 | CN1620413B 还原型辅酶Q<sub>10</sub>的稳定方法和组合物 Coenzyme Q <sub> 10 </ sub> stabilization methods and compositions |
| 02/08/2012 | CN102348703A Compounds for the treatment of metabolic disorders |
| 02/08/2012 | CN102348459A Plasma-adapted full electrolyte solution |
| 02/08/2012 | CN102344880A Health wine and production method thereof |
| 02/08/2012 | CN102344491A Interferon alpha antibodies and their uses |
| 02/08/2012 | CN102344468A Preparation and use of novel AKT/PKB kinase agonists |
| 02/08/2012 | CN102344457A Spirocyclic aminoquinolones as gsk-3 inhibitors |
| 02/08/2012 | CN102344442A Novel crystal form of tandospirone citrate and preparation method and application thereof |
| 02/08/2012 | CN102344398A 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 02/08/2012 | CN102344360A Preparation method of arginine dexibuprofen |
| 02/08/2012 | CN102343100A Method for quickly preparing rutin inclusion compound |
| 02/08/2012 | CN102343053A Traditional Chinese medicine for treating hyperlipemia |
| 02/08/2012 | CN102343037A Drug with effects of bacterium resistance, disinfection, blood circulation promotion, blood stasis removal, immunity improvement, life prolonging and aging delay |
| 02/08/2012 | CN102343026A Traditional Chinese medicine composition for treating diabetes and preparation method thereof |
| 02/08/2012 | CN102343023A Medicinal composition and preparation method and application thereof |
| 02/08/2012 | CN102343013A Camellia saponin controlled release tablet and preparation method thereof |
| 02/08/2012 | CN102342959A Serum pharmacochemistry preparation method of Chinese medicinal weight-reducing prescription |
| 02/08/2012 | CN102342955A Pharmaceutical composition for treating hyperphosphatemia and preparation thereof |
| 02/08/2012 | CN102342951A Chickweed flavonoid glycoside extract, its preparation method and pharmaceutical application |
| 02/08/2012 | CN102342938A Methods and compositions for treatment and management of cancers |
| 02/08/2012 | CN102342936A Medicinal composition of amlodipine and atorvastatin calcium and its preparation method |
| 02/08/2012 | CN102342935A Berberine-phenylacetic acid derivative, pharmaceutically acceptable salt thereof and application thereof |
| 02/08/2012 | CN102342924A Medicine composition containing agomelatine |
| 02/08/2012 | CN102342922A Solid preparation using edetic acid ferrisodium as active ingredient |
| 02/08/2012 | CN102342913A Intra-intestinal nutrient emulsion for tumor patients and preparation method thereof |
| 02/08/2012 | CN102342906A Oral liquid preparation with ethylenediaminetetraacetic acid iron sodium as active component |
| 02/08/2012 | CN102342330A Oil and fat composition containing diglyceride and use thereof |
| 02/08/2012 | CN102342301A Foliage conditioner prepared from straw and household kitchen biomass carbonization byproducts and application thereof |
| 02/08/2012 | CN101919851B 治疗哺乳动物包括人2型糖尿病的药物组合物 Pharmaceutical compositions comprising treating people with type 2 diabetes |
| 02/08/2012 | CN101919835B 2-乙酰氨基龙胆酸作为制备胰岛素增敏剂的用途 2-acetyl-amino acid long as the preparation of the use of insulin sensitizers |
| 02/08/2012 | CN101912388B 逆向蒸发-高压微射流制备中链脂肪酸-维生素c脂质体 Reverse evaporation - the preparation of high-pressure micro jet-chain fatty acid - vitamin c liposomes |
| 02/08/2012 | CN101904840B 治疗哺乳动物包括人2型糖尿病的药物组合物 Pharmaceutical compositions comprising treating people with type 2 diabetes |
| 02/08/2012 | CN101829237B 用于治疗痰浊瘀阻证引起的高血脂症药物及其制备工艺 Drugs for the treatment of hyperlipidemia caused by phlegm stasis and preparation process |
| 02/08/2012 | CN101708212B 核桃油阿胶 Walnut oil gelatin |
| 02/08/2012 | CN101691568B 一种可食性固定化活性益生菌的生产方法 One kind of edible immobilized active probiotic production methods |
| 02/08/2012 | CN101641361B 四氢咪唑并[1,5-a]吡嗪类衍生物，其制备方法及其在医药上的应用 Tetrahydroimidazo [1,5-a] pyrazine derivatives, their preparation and their applications in medicine |
| 02/08/2012 | CN101541760B 二氨基环己烷和二氨基环戊烷衍生物 Diaminocyclohexane and di-amino-cyclopentane derivatives |
| 02/08/2012 | CN101234142B 一种以辅助降血糖为主的桑系列保健功能性饮料 A kind of auxiliary hypoglycemic Sang-based series of health functional beverages |
| 02/08/2012 | CN101172126B 一种保健美容用中药组合物 A health cosmetic herbal composition |
| 02/08/2012 | CN101092402B 磺酰脲类化合物及其医药用途 Sulfonylurea compounds and their pharmaceutical use |
| 02/08/2012 | CN101062906B 胍丁胺硫酸盐水合物及其用于戒毒,抗炎,降血糖以及胍丁胺代谢异常所致疾病的用途 Agmatine sulfate hydrate thereof for detoxification, anti-inflammatory, hypoglycemic and agmatine metabolism disorders caused by abnormal use |